Parametrica Management’s Pacira BioSciences PCRX Stock Holding History

Parametrica Management’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-5,249	Closed	-$275K	–	141
2020 Q2	$275K	Buy	+5,249	New	+$219K	0.3%	86
2019 Q1	–	Sell	-6,398	Closed	-$275K	–	277
2018 Q4	$275K	Buy	6,398 +1,138	+22%	+$53.1K	0.34%	147
2018 Q3	$259K	Buy	+5,260	New	+$227K	0.57%	86
2016 Q3	–	Sell	-10,035	Closed	-$338K	–	211
2016 Q2	$338K	Buy	+10,035	New	+$493K	0.51%	70
2016 Q1	–	Sell	-4,231	Closed	-$325K	–	121
2015 Q4	$325K	Sell	4,231 -1,886	-31%	-$107K	2.14%	14
2015 Q3	$251K	Buy	+6,117	New	+$375K	1.58%	27
2014 Q4	–	Sell	-2,425	Closed	-$235K	–	69
2014 Q3	$235K	Buy	+2,425	New	+$236K	1.37%	35

Other funds holding PCRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

SCM

Spyglass Capital Management San Francisco, California $1.85B AUM 15.7% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Parametrica Management's PCRX Position: Q3 2020 in Review

Parametrica Management sold out of Pacira BioSciences (PCRX) in Q3 2020, closing a stake of 5,249 shares — an estimated $275K sold.

Parametrica Management first reported a position in PCRX in Q3 2014 and held it in 7 quarters. The position peaked at $338K in Q2 2016. 257 funds tracked by Wall St. Rank hold PCRX as of Q3 2020.

Parametrica Management reported no remaining Pacira BioSciences position as of Q3 2020 after selling out during the quarter.
Parametrica Management sold 5,249 Pacira BioSciences shares in Q3 2020, an estimated $275K.
Parametrica Management first reported a position in Pacira BioSciences in Q3 2014 and held it in 7 quarters.
Parametrica Management's Pacira BioSciences position peaked at $338K in Q2 2016.
257 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2020.

Based on Parametrica Management's 13F filing for Q3 2020, filed 13 Nov 2020.